drugset / Trial / NCT05824065
Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this clinical trial is to evaluate the efficacy and safety of OMA102 1 mg and OMA102 2 mg versus placebo in the treatment of female pattern hair loss.
Timeline
- Start
- 2025-01
- Primary completion
- 2027-01
- Completion
- 2027-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OMA102 | Unknown | 1 mg | Oral |
| Subject | OMA102 | Unknown | 2 mg | Oral |